S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Stock market today: Wall Street dips to send S&P 500 to its longest losing streak since January
Abbott Laboratories Outlook is Healthy: Buy the Dip
Prologis Stock Leading U.S. Logistics Boom
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Stock market today: Wall Street dips to send S&P 500 to its longest losing streak since January
Abbott Laboratories Outlook is Healthy: Buy the Dip
Prologis Stock Leading U.S. Logistics Boom
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Stock market today: Wall Street dips to send S&P 500 to its longest losing streak since January
Abbott Laboratories Outlook is Healthy: Buy the Dip
Prologis Stock Leading U.S. Logistics Boom
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Stock market today: Wall Street dips to send S&P 500 to its longest losing streak since January
Abbott Laboratories Outlook is Healthy: Buy the Dip
Prologis Stock Leading U.S. Logistics Boom
NYSE:SENS

Senseonics (SENS) Stock Price, News & Analysis

$0.40
-0.03 (-6.94%)
(As of 04/17/2024 ET)
Today's Range
$0.40
$0.44
50-Day Range
$0.40
$0.73
52-Week Range
$0.40
$1.05
Volume
4.99 million shs
Average Volume
2.51 million shs
Market Capitalization
$213.49 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$1.25

Senseonics MarketRank™ Stock Analysis

Analyst Rating
Hold
2.00 Rating Score
Upside/​Downside
210.8% Upside
$1.25 Price Target
Short Interest
N/A
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
N/A
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($0.13) to ($0.11) Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

0.37 out of 5 stars

Medical Sector

881st out of 914 stocks

Process Control Instruments Industry

12th out of 12 stocks

SENS stock logo

About Senseonics Stock (NYSE:SENS)

Senseonics Holdings, Inc., a medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. The company's products include Eversense, Eversense XL, and Eversense E3 that are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management. It serves healthcare providers and patients through a network of distributors and strategic fulfillment partners. Senseonics Holdings, Inc. was founded in 1996 and is headquartered in Germantown, Maryland.

SENS Stock Price History

SENS Stock News Headlines

Claim Your Complimentary Bitcoin Reward
Many have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached.
A new way to collect income from stocks
Most people think of BUYING options when they talk about options. It’s how speculators leverage large sums of money hoping that a stock moves in the “right” direction over a certain period of time. The problem is - they don’t always pay off when you buy them. In fact, a contributing writer at the Financial Post studied options extensively…
Q4 2023 Senseonics Holdings Inc Earnings Call
Senseonics: Q4 Earnings Snapshot
Here's what to expect from Senseonics's earnings
SENS Jan 2026 1.500 put
SENS Mar 2024 0.500 call
Senseonics Holdings Inc
Senseonics Holdings Inc SENS
See More Headlines
Receive SENS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Senseonics and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/29/2024
Today
4/17/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Process control instruments
Sub-Industry
N/A
Employees
132
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$1.25
High Stock Price Target
$2.00
Low Stock Price Target
$0.50
Potential Upside/Downside
+189.3%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
2 Analysts

Profitability

Net Income
$-60,390,000.00
Net Margins
-270.13%
Pretax Margin
-269.73%

Debt

Sales & Book Value

Annual Sales
$22.39 million
Book Value
$0.07 per share

Miscellaneous

Free Float
502,012,000
Market Cap
$229.37 million
Optionable
N/A
Beta
0.87
7 Energy Stocks to Buy and Hold Forever Cover

Do you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.

Get This Free Report

Key Executives

  • Dr. Timothy T. Goodnow Ph.D. (Age 62)
    President, CEO & Director
    Comp: $1.34M
  • Dr. Mukul Jain (Age 51)
    Chief Operating Officer
    Comp: $767.65k
  • Mr. Kenneth L. Horton (Age 57)
    General Counsel & Corporate Development Advisor
    Comp: $702.33k
  • Dr. Francine Ratner Kaufman M.D. (Age 72)
    Chief Medical Officer & Director
  • Mr. Frederick T. Sullivan (Age 42)
    CFO, Secretary & Treasurer

SENS Stock Analysis - Frequently Asked Questions

Should I buy or sell Senseonics stock right now?

2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Senseonics in the last year. There are currently 1 sell rating and 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" SENS shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in SENS, but not buy additional shares or sell existing shares.
View SENS analyst ratings
or view top-rated stocks.

What is Senseonics' stock price target for 2024?

2 equities research analysts have issued 1 year price targets for Senseonics' shares. Their SENS share price targets range from $0.50 to $2.00. On average, they anticipate the company's stock price to reach $1.25 in the next year. This suggests a possible upside of 210.8% from the stock's current price.
View analysts price targets for SENS
or view top-rated stocks among Wall Street analysts.

How have SENS shares performed in 2024?

Senseonics' stock was trading at $0.5701 on January 1st, 2024. Since then, SENS shares have decreased by 29.5% and is now trading at $0.4022.
View the best growth stocks for 2024 here
.

How were Senseonics' earnings last quarter?

Senseonics Holdings, Inc. (NYSE:SENS) issued its earnings results on Thursday, February, 29th. The company reported ($0.03) EPS for the quarter, topping the consensus estimate of ($0.04) by $0.01. The firm earned $8 million during the quarter, compared to analysts' expectations of $7.62 million. Senseonics had a negative net margin of 270.13% and a negative trailing twelve-month return on equity of 146.90%.

What guidance has Senseonics issued on next quarter's earnings?

Senseonics issued an update on its FY 2023 earnings guidance on Tuesday, January, 30th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $22.0 million-$22.0 million, compared to the consensus revenue estimate of $21.8 million.

When did Senseonics IPO?

Senseonics (SENS) raised $45 million in an IPO on Friday, March 18th 2016. The company issued 15,800,000 shares at $2.85 per share. Leerink Partners, Canaccord Genuity and Raymond James acted as the underwriters for the IPO and BTIG was co-manager.

How do I buy shares of Senseonics?

Shares of SENS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSE:SENS) was last updated on 4/17/2024 by MarketBeat.com Staff

From Our Partners